- Home
- PHAR vs KIDS Comparison
PHAR vs KIDS Comparison
Compare PHAR & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- KIDS
- Stock Information
- Founded
- PHAR 1988
- KIDS 2007
- Country
- PHAR Netherlands
- KIDS United States
- Employees
- PHAR N/A
- KIDS N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- KIDS Medical/Dental Instruments
- Sector
- PHAR Health Care
- KIDS Health Care
- Exchange
- PHAR Nasdaq
- KIDS Nasdaq
- Market Cap
- PHAR 1.0B
- KIDS 524.3M
- IPO Year
- PHAR N/A
- KIDS 2017
- Fundamental
- Price
- PHAR $13.89
- KIDS $19.56
- Analyst Decision
- PHAR Strong Buy
- KIDS Strong Buy
- Analyst Count
- PHAR 3
- KIDS 7
- Target Price
- PHAR $30.00
- KIDS $34.14
- AVG Volume (30 Days)
- PHAR 11.8K
- KIDS 137.2K
- Earning Date
- PHAR 10-23-2025
- KIDS 11-05-2025
- Dividend Yield
- PHAR N/A
- KIDS N/A
- EPS Growth
- PHAR N/A
- KIDS N/A
- EPS
- PHAR N/A
- KIDS N/A
- Revenue
- PHAR $339,836,000.00
- KIDS $220,733,000.00
- Revenue This Year
- PHAR $16.63
- KIDS $19.26
- Revenue Next Year
- PHAR $6.77
- KIDS $17.15
- P/E Ratio
- PHAR N/A
- KIDS N/A
- Revenue Growth
- PHAR 22.44
- KIDS 26.08
- 52 Week Low
- PHAR $7.31
- KIDS $16.59
- 52 Week High
- PHAR $17.08
- KIDS $32.93
- Technical
- Relative Strength Index (RSI)
- PHAR 52.44
- KIDS 43.35
- Support Level
- PHAR $13.51
- KIDS $19.06
- Resistance Level
- PHAR $15.61
- KIDS $21.35
- Average True Range (ATR)
- PHAR 0.92
- KIDS 0.94
- MACD
- PHAR -0.12
- KIDS -0.10
- Stochastic Oscillator
- PHAR 30.89
- KIDS 13.39
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.